Atricure to participate in the 41st annual j.p. morgan healthcare conference

Mason, ohio--( business wire )--atricure, inc. (nasdaq: atrc), a leading innovator in surgical treatments for atrial fibrillation (afib), left atrial appendage (laa) management, and post-operative pain management, today announced that the company will be participating in the upcoming 41st annual j.p. morgan healthcare conference.
ATRC Ratings Summary
ATRC Quant Ranking